Bustin, Stephen A. (2013) Transparency of reporting in molecular diagnostics. International Journal of Molecular Sciences, 14 (8). pp. 15878-15884. ISSN 1422-0067
|
Text
Published Version Available under the following license: Creative Commons Attribution. Download (160kB) | Preview |
Abstract
The major advances made over the past few years in molecular and cell biology are providing a progressively more detailed understanding of the molecular pathways that control normal processes and become dysregulated in disease. This has resulted in the documentation of numerous genetic, epigenetic, transcriptomic, proteomic and metabolomic biomarkers that promise earlier disease detection, more accurate patient stratification and better prognosis. Furthermore, molecular fingerprinting of diseases can be predictive of drug response and so assist with specific targeting of drugs against disease-associated molecules and function.
Item Type: | Journal Article |
---|---|
Keywords: | Editorial |
Faculty: | ARCHIVED Faculty of Health, Social Care & Education (until September 2018) |
Depositing User: | Repository Admin |
Date Deposited: | 02 Sep 2013 14:23 |
Last Modified: | 09 Sep 2021 19:02 |
URI: | https://arro.anglia.ac.uk/id/eprint/300630 |
Actions (login required)
![]() |
Edit Item |